Westborough, MA, April 30, 2026 — Effective April 15, 2026, AM Best has reaffirmed Eastern Dentists Insurance Company’s (EDIC) Financial Strength Rating of A- (Excellent) with a stable outlook. EDIC, domiciled in Burlington, Vermont, is a leading dental professional liability insurer created and governed by dentists, for dentists. AM Best’s rating reflects EDIC’s excellent financial strength and claims paying ability. AM Best credit ratings serve as independent evaluations of an insurer’s financial stability and its ability to meet ongoing policy and contractual obligations, offering a trusted benchmark for both consumers and industry professionals.

“We are pleased that AM Best continues to recognize EDIC’s prudent financial management and commitment to its policyholders,” said Dr. Stephen McKenna, Chairman of the Board of EDIC.

In its report, AM Best stated that the latest rating decision was based in part on EDIC’s financial strength at the highest level as “strongest,” organic surplus growth through earnings, favorable loss reserve development as reported in each of the prior ten years, and high quality of capital. The report also notes EDIC’s strong, seasoned management team with significant industry experience specific to MPL and dentistry.

About EDIC – Founded in 1992, Eastern Dentists Insurance Company (EDIC) is a mutual-based company located in Westborough, MA governed by dentists and owned by dental policyholders. We remain steadfast in our commitment to the field of dentistry as well as our dental institutions and students. The company has grown to include thousands of dental colleagues in Massachusetts, Rhode Island, Connecticut, New Hampshire, Vermont, Maine, New Jersey, New York, Pennsylvania, Virginia, North Carolina, Michigan, and Indiana. For more information, visit EDIC’s website at www.edic.com.

Copyright ©2026 Eastern Dentists Insurance Company. All rights reserved.

The post Press Release: AM Best Reaffirms Excellent Credit Rating of Eastern Dentists Insurance Company appeared first on Eastern Dentists Insurance Company (EDIC).

As the population ages, the incidence of diseases requiring antiresorptive therapy is also increasing. The term antiresorptive therapy refers to the administration of oral or parenteral medications to reduce or stop the loss of bone mass associated with ailments like osteoporosis, osteopenia, metastatic cancer to the bone, and hypercalcemia.

There are two main class of drugs used to combat bone fractures and skeletal related events – Denosumab and Bisphosphonate. The most common complication in patients on antiresorptive therapy is osteonecrosis of the jaw, or medication-related osteonecrosis of the jaw (MRONJ), which can occur after any surgical dental procedure.

At present, there is no effective treatment for MRONJ, so prevention is extremely important. Maximum precautions should be taken in patients who are at the risk of development of osteonecrosis, especially with dental surgical procedures like extractions, retrograde apicoectomies, periodontal surgery, or implant placements. Dentists should keep up to date with the latest prevention guidelines and the risk factors when treating patients who are on antiresorptive therapy.

It’s important to include a question regarding antiresorptive therapy in your medical history form and to incorporate this information into your treatment planning.

EDIC has a Bisphosphonate Consent Form. Here is also a clinical piece, “Antiresorptive Therapy: Roles and Responsibilities of Dental Professionals,” by Reza Radmand, DMD, FAAOM.

The post Antiresorptive Therapy: Roles and Responsibilities of Dental Professionals appeared first on Eastern Dentists Insurance Company (EDIC).